Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 6 March 2001
Vol. 2001, Issue 72, p. tw4
[DOI: 10.1126/stke.2001.72.tw4]

EDITORS' CHOICE

Cell Cycle Loss of FKBP12 Applies the Brakes

FKBP12 is a 12-kD protein originally identified as the physiologic target for the immunosuppressive drug FK506. FKBP12 is widely expressed and attenuates the activity of inositol trisphosphate receptors, ryanodine receptors, and transforming growth factor β receptors (TGFβRs). FKBP12 is essential, and knockout mice die as embryos; however, Aghdasi et al. were able to study embryonic fibroblasts from FKBP12-/- mice in culture. The FKBP12-/- fibroblasts divided more slowly than did wild-type fibroblasts and exhibited cell-cycle arrest in G1, which could be overcome in cells expressing a dominant negative TGFβR mutant. Analysis of the potential signaling pathways activated by TGFβR (SMAD pathway or the ERK or p38 mitogen-activated kinase pathways) indicated that the hyperactive TGFβR pathway responsible for the cell-cycle arrest was the p38 pathway leading to overexpression of the cyclin-dependent kinase inhibitor p21.

B. Aghdasi, K. Ye, A. Resnick, A. Huang, H. C. Ha, X. Guo, T. M. Dawson, V. L. Dawson, S. H. Snyder, FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycle. Proc. Natl. Acad. Sci. U.S.A. 98, 2425-2430 (2001). [Abstract] [Full Text]

Citation: Loss of FKBP12 Applies the Brakes. Sci. STKE 2001, tw4 (2001).


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882